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Sir,
In a recent interesting study by Monroe et al (2007), grapefruit
intake was associated with an increase in breast cancer risk, and
they hypothesised that this might be mediated by an effect on
endogenous oestrogen levels. However, the researchers were unable
to examine grapefruit juice intake. Therefore, we examined grape-
fruit and grapefruit juice intake and breast cancer risk in the Nurses’
Health Study. Briefly, the Nurses’ Health Study is a prospective
cohort consisting of women aged 30–55 years in 1976 (Kim et al
2006). Medical and lifestyle information was obtained with general
follow-up questionnaires every 2 years and with semi quantitative
food frequency questionnaires that included intakes of grapefruit
and grapefruit juice in 1984, 1986, 1990, 1994, and 1998. In both age-
adjusted (not shown) and multivariate analyses adjusted for
standard breast cancer risk factors, we found no overall association
with either grapefruit or grapefruit juice intake and breast
cancer risk among all women in the cohort, and among
postmenopausal women only (Table 1). Furthermore, our results
did not change once additional covariates – alcohol, saturated fat,
dietary fibre, and soluble fibre – included by Monroe et al were
added to our models.
Stratification by BMI did not alter the breast cancer risk with
either grapefruit or grapefruit juice intake. However, stratification
by hormone therapy showed a significant decrease in risk of breast
cancer with greater intake of grapefruit in women who never used
hormone therapy (multivariate RR comparing 1
4 grapefruit or more
per day to none¼0.78, 95% CI, 0.59–1.04, P trend¼0.03). This is
contrary to the findings of Monroe et al, who observed a
significant increase in risk of breast cancer with greater
consumption of grapefruit in this subgroup.
Table 1 Multivariate relative risks of breast cancer incidence between 1984 and 2002 by cumulatively averaged grapefruit and grapefruit juice intake
All women 77050 subjects (total cases¼4315)
Grapefruit (per day) 0 40–1/8 X1/8–1/4 X1/4 P Trend
Cases 969 2576 539 231
Multivariate RR (95% CI) 1.00 1.02 (0.94, 1.10) 0.96 (0.86, 1.07) 1.00 (0.86, 1.15) 0.5
Grapefruit juice (small glass per day) 0 40–1/4 X1/4–1/2 X1/2 P Trend
Cases 2335 1571 265 144
Multivariate RR (95% CI) 1.00 0.96 (0.89, 1.02) 1.01 (0.89, 1.15) 0.95 (0.80, 1.13) 0.52
Postmenopausal women only 73411 subjects (total cases¼3570)
Grapefruit (per day) 0 40–1/8 X1/8–1/4 X1/4 P Trend
Cases 732 2169 469 200
Multivariate RR (95% CI) 1.00 1.03 (0.95, 1.12) 0.97 (0.86, 1.09) 0.97 (0.83, 1.14) 0.34
Grapefruit juice (small glass per day) 0 40–1/4 X1/4–1/2 X1/2 P Trend
Cases 1853 1360 228 129
Multivariate RR (95% CI) 1.00 0.99 (0.92, 1.06) 1.04 (0.90, 1.19) 1.02 (0.85, 1.22) 0.95
Values are adjusted for energy, age, time period, height, parity, age at first birth, weight change since age 18 years, body mass index at age 18 years, age at menopause, use of
hormone replacement therapy, family history of breast cancer, benign, breast disease, age at menarche and physical activity.
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fruit juice) intake and breast cancer risk differed significantly
by oestrogen and progesterone receptor status of the tumours.
No association was observed in women with oestrogen and
progesterone receptor positive cancers. However, in women
with oestrogen and progesterone receptor negative cancers,
there was a significant decrease in breast cancer risk with
increased consumption of grapefruit (multivariate RR comparing
1
4 grapefruit or more per day to none¼0.60, 95% CI, 0.37–0.98,
P trend¼0.03).
We also examined cross-sectionally the relationship between
consumption of grapefruit and grapefruit juice and plasma
levels of oestrogens among 701 postmenopausal women not
using hormone replacement. No significant correlation was
observed (grapefruit, grapefruit juice) for plasma oestradiol
(r¼0.02,  0.04), oestrone (r¼0.00,  0.02), or oestrone sulphate
(0.09, 0.01).
Our findings do not support an adverse effect of consumption
of grapefruit or grapefruit juice on risk of breast cancer or on
endogenous hormone levels.
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